News

Drug Delivery Business

Tandem reports positive outcomes for automated insulin delivery in type 2 regardless of C-peptide levels

Tandem Diabetes Care (Nasdaq:TNDM) today announced study findings highlighting the benefits of its automated insulin delivery ...
Morningstar

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide ...

Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...
Health on MSN

Type 1.5 Diabetes Is a Controversial Diagnosis—Here's What To Know

Medically reviewed by Isabel Casimiro, MD, PhD Type 1.5 diabetes has features of both type 1 and type 2 diabetes.People with ...